ベガウォレット入金方法

If Javascript is turned off, turn it on. Purpose Impact Domains Drivers Open Search Open Profile Investors Careers Newsroom Contact Us JP EN Open Search Open Products Information Search Close JP EN Purpose Impact Domains Drivers Profile Investors Careers Newsroom Contact Us Using this Website Privacy Policy Site Map Products Information Close Purpose Purpose Impact Domains Drivers Profile Investors Newsroom Purpose Message from Top Management CSV Purpose Long-term Management Vision and Medium-Term Business Plan KIRIN’s HISTORY Corporate Governance Risk Management Value Creation Model About Kirin Group Impact The Origin and Progress of CSV Management CSV Management Management Issues for Sustainable Growth (Group Materiality Matrix) A Responsible Alcohol Producer Health and Well-Being Community Engagement 　Respect for human rights The Environment Other material agenda and governance Domains Product brands Food & Beverages Health Science Pharmaceuticals Drivers Core technology that assures value creation Consumer centric marketing ICT accelerating value creation Diversity and inclusion, culture for innovation Financial strategy Profile Corporate Policy Corporate Overview Management Group Companies Company History Our Approaches in Quality Investors Management Policy Chart Generator Financial Data Non-Financial Information Share-related Information IR Library Individual Investors IR Events Calendar IR website user guide Disclaimer FAQs Third-Party Evaluations Newsroom News Releases Media kit Media Contacts Long-term Management Vision and Medium-Term Business Plan Management Plan Releases and Presentations Value Creation Model Value Creation Story Corporate Governance Overview Management Structure Management, Leadership & Advisory Remuneration System for Executive Officers Risk Management Compliance Kirin Group Tax Policy CSV Management 2022-2024 CSV Commitments Establishment and Operation of the Group CSV Committee Group Sustainability Meetings on Specific Issues Stakeholder Engagement Endorsement and participation in external organizations and initiatives United Nations Global Compact Policies Social contribution activities Sustainable Finance Marketing Communication Policy(MCP) Health and Well-Being What is “Health & Well-being” in Kirin Group? Ensuring food safety and security Ensuring stable supply, safety and reliability as a pharmaceutical company Provide pharmaceuticals for Unmet Medical Needs Support for maintaining the immune system Ensuring occupational health and safety Support for the prevention of non-communicable diseases Implementation of health management Helping to improve the performance of brain function and prevent decline Improvement of access to nutrition Community Engagement Respect for human rights Sustainable development of communities in raw material production areas and business development regions Creating bonds and trust for people's well-being Enhancing the sustainability of food economy Sustainable supply chain Community Topics Respect for human rights Kirin Group Human Rights Policy Embedding the Kirin Group Human Rights Policy in practice Implementing Human Rights Due Diligence The Environment Sustainable use of biological resources Sustainable use of water resources Sustainable recycling of containers and packaging Overcoming climate change Kirin Group's Environmental Vision 2050 Message from Top Management Engagement Vision / Policies / Structure Environmental management and CSV Holistic Environmental Management Information Disclosure Based on the TCFD Framework, TNFD Framework Draft, etc. Our Holistic Approach Third-Party Evaluations of environment Environmental Topics A Responsible Alcohol Producer Dealing with alcohol-related problems Policy and System Food and Beverages Kirin Brewery Company, Limited Lion Pty Ltd Kirin Beverage Company, Limited Mercian Coca-Cola Beverages Northeast, Inc. Health Science domain Message from Senior Executive Officer of Health Science Strategy Kirin Holdings Company, Limited Kyowa Hakko Bio Co., Ltd. Koiwai Dairy Products Co., Ltd. Kirin Beverage Company, Limited Core technology that assures value creation Accelerating intellectual property activities that leverage technological capabilities for the business Diversity and inclusion, culture for innovation Strengthening the human capital capability Diversity Cultivating the organizational culture Corporate Policy Achieving "Joy brings us together" The Story Behind Kirin Beer Labels Corporate Overview Barrier-free route to Kirin Group Head Office Group Companies Kirin Brewery Company, Limited Kirin Beverage Company, Limited Mercian Corporation Company History 1885‐1949 1950‐1989 1990‐1999 2000‐2009 2010‐2019 2020‐ Our Approaches in Quality Quality management Ensuring Product Safety and Reliability in the Food & Beverages Domain Ensuring Product Safety and Reliability in the Health Science Domain Chart Generator Yearly Data Quarterly Data Management Policy Corporate Disclosure Policy Financial Data Message from the Chief Financial Officer Management Analysis Of Financial Position, Operating Results, And Cash Flows Business Segments Consolidated Balance Sheets Consolidated Statements of Income Statements of Cash Flows Non-Financial Information Message from Senior Executive Officer of CSV Strategy ESG Databook Guideline Content Index Share-related Information General Meetings of Shareholders Dividend Payments and Own-share Repurchase Stock Information Share Data Stock Quote Bonds and Rating Analyst Coverage Articles of Incorporation and Regulations Public Notice IR Library Financial Results（Financial Results/Presentations/Financial Statements） IR News Releases IR Events Releases and Presentations Archive Integrated Report Investor’s Guide Market data and Sales Kirin Group Environmental Report Management Plan Releases and Presentations Long-term (Archive) Medium-term (Archive) Current Fiscal Year (Archive) Management Structure Interview with Independent Non-executive Directors 2022-2024 CSV Commitments 2019-2021 CSV Commitments Social contribution activities The Pink Ribbon Activity JICA-KIRIN Fellowship Program Marketing Communication Policy(MCP) Guidelines of Product Labeling Respect for human rights Kirin Group Human Rights Policy Embedding the Kirin Group Human Rights Policy in practice Implementing Human Rights Due Diligence Sustainable development of communities in raw material production areas and business development regions Japanese hops Tea Leaves Vineyards Sustainable supply chain Policy on Sustainable Procurement Activities to Promote Sustainable Procurement Working Together with Suppliers Engagement Dialogue 01 Dialogue 02 Dialogue 03 Dialogue 04 Dialogue 05 Holistic Environmental Management Information Disclosure Based on the TCFD Framework, TNFD Framework Draft, etc. Risks and Opportunities Dealing with alcohol-related problems What is Slow Drinking? Other initiatives in Japan Business Segments Year Quarter Consolidated Balance Sheets Year Quarter Consolidated Statements of Income Year Quarter Statements of Cash Flows Year Quarter General Meetings of Shareholders Previous Fiscal Years Financial Results（Financial Results/Presentations/Financial Statements） Archive IR Events Releases and Presentations Archive KIRIN R＆D DAY 2020 Archive Integrated Report Integrated Report PDF Kirin Integrated Report 2023 Kirin Integrated Report 2022 Kirin Integrated Report 2021 KIRIN CSV REPORT 2020 KIRIN CSV REPORT 2019 KIRIN REPORT 2018 KIRIN REPORT 2016 KIRIN REPORT 2015 Annual Reports (Back numbers) Market data and Sales Domestic sale outline report(Monthly) Domestic Monthly sales report(Archive) Domestic Alcohol market data(Year) Beer consumption by region(Year) Beer consumption by country(Year) Domestic Soft drink market data(Year) Kirin Group Environmental Report Archive Kirin Group Human Rights Policy Feedback from stakeholders during the establishment of the 2018 Human Rights Policy Activities to Promote Sustainable Procurement Past Reports on human rights impact assessments of supply chains JICA-KIRIN Fellowship Program Greetings from the Host Institution Representatives Overview Fellow Introduction About United Nations University-Kirin Fellowship KIRIN CSV REPORT 2020 Message from Top Management Past and Present Special Feature: Growth Strategies for the Health Science Domain Strengthening Organizational Capabilities Financial and Non-financial Highlights Message from the Chief Financial Officer Interview with the Non-executive Director KIRIN CSV REPORT 2019 Message from Top Management Interview with the Chief Financial Officer Strengthening Our Non-Financial Assets CSV Stories CASE1 Pharmaceuticals business CSV Stories CASE2 Businesses bridging Pharmaceuticals and Food & Beverages CSV Stories CASE3 Community Engagement CSV Stories CASE4 The Environment CSV Stories CASE5 A Responsible Alcohol Producer Discussion with Management Interview with an Outside Director Financial and Non-financial Highlights Past and Present KIRIN REPORT 2018 Message from Top Management Discussion with Management, Part1 Discussion with Management, Part2 Interview with an Outside Director CASE1 Kirin Ichiban Shibori Relaunch and Craft Beer Market Development CASE2 Pharmaceuticals for Worldwide Markets CASE3 Lactococcus lactis strain Plasma Stars in New Products CASE4 Advanced High-Efficiency Facilities at Myanmar Brewery History of the Kirin Group The Kirin Group Today Overview by segment and business for fiscal 2017 Management's discussion & analysis Financial & Non-Financial Highlights KIRIN REPORT 2016 To Our Stakeholders Long-Term Management Vision and Medium-Term Business Plan CFO’s Message Overview of the Kirin Group’s Business Kirin’s Foundation for Value Creation Interview with an Outside Director KIRIN REPORT 2015 KEY POINTS ABOUT KIRIN Long-Term Management Vision and Medium-Term Business Plan KIRIN’S GROWTH STRATEGIES A Conversation between Outside Directors Management Issues for Sustainable Growth (Group Materiality Matrix) Technology (R&D) Foundation SCM Foundation Human Resources Foundation Fellow Introduction 2019 Fellow Researchers and Research Themes 2018 Fellow Researchers and Research Themes 2017 Fellow Researchers and Research Themes About United Nations University-Kirin Fellowship List of Former United Nations University-Kirin Fellows Special Feature: Growth Strategies for the Health Science Domain Strategic Decisions in 2019 / Message from the Officer in Charge of Health Business Strategy Part1 Interview with the Executive Officer of R&D Strategy Part2 Creating Synergies with FANCL Corporation Strengthening Organizational Capabilities Enhancing Kirin Beverage's marketing capabilities Development of our human resources Strengthening Our Non-Financial Assets Honkirin and our marketing reform R&D Strategy:Technology creating trusted value Human resources strategies:Diversity and inclusion, culture for innovation Financial & Non-Financial Highlights Financial Highlights Non-Financial Highlights To Our Stakeholders Kirin’s Management Environment,Vision, and Strategies Progress with the Medium-Term Business Plan Issues and Future Initiatives Aiming to Be a Company That Is Completely Trusted Long-Term Management Vision and Medium-Term Business Plan Long-Term Management Vision Medium-Term Business Plan Recognizing the Challenges and Future Initiatives Kirin’s Foundation for Value Creation The Kirin Group’s Value Creation Marketing Research & Development Supply Chain KEY POINTS ABOUT KIRIN Business Structure / Earnings Structure Kirin's History of Progress Long-Term Management Vision and Medium-Term Business Plan Long-Term Management Vision Medium-Term Business Plan List of Former United Nations University-Kirin Fellows 2016 Fellow's Research Projects 2015 Fellow's Research Projects 2014 Fellow's Research Projects 2013 Fellow's Research Projects 2012 Fellow's Research Projects 2011 Fellow's Research Projects 2010 Fellow's Research Projects 2009 Fellow's Research Projects Close Home Newsroom News Releases 2023 L. lactis strain Plasma Series Sales Increase 40% From January To June Of This Year ［Health Science domain］ L. lactis strain Plasma Series Sales Increase 40% From January To June Of This Year CSV Products and Services Print August 10, 2023 Kirin Holdings Company, Limited ● Consumers continue to be aware of their own health care needs ● A wide range of products including foods, non-alcoholic beverages, and supplements (52, as of 2023) provide accessibility towards instilling an “immune care” habit among consumers ● The recognition rate of the importance of immune care up 8.9 points for the period TOKYO, Thursday August 10, 2023- Kirin Holdings Company, Limited (Kirin Holdings) has reported a year-on-year increase of approximately 40% in sales of its proprietary ingredient Lactococcus lactis strain Plasma (L. lactis strain Plasma, a postbiotic) in Japan and overseas from January to June of this year. Factors behind the strong performance (1) Establishment of health measures that can be easily taken on a daily basis With the recent changes in the environment, there is a growing need to maintain a healthy body and mind. Approaches to maintaining good health are not something that require a lot of money, time and effort, but people rather prefer easy approaches that they can implement in their daily lives, such as a regular lifestyle and daily diet, and a survey score for " I continue eat certain foods for my health" has improved compared to 2019. *1 The functional food market has also continued to grow in recent years, with sales of functional food products such as soft drinks and supplements increasing due to key factors such as ease of purchase by consumers, including the ability to purchase these products at familiar sales outlets such as supermarkets and convenience stores.*2 This indicates that more and more consumers want to maintain their daily health habits more easily. *1 Intage Knowledge Gallery April 25, 2023 Published article New Living Landscape - Series: Past and Future (1) Awareness of Safety and Security https://gallery.intage.co.jp/ihr-column35/ (Japanese) *2 Yano Research Institute Ltd. "Research on Health Food Market (2023)" (released April 14, 2023) https://www.yano.co.jp/press-release/show/press_id/3235 (Japanese) (2) Expanding awareness of "Immune-Care" and a lineup that meets consumer needs To meet the needs of our consumers who want to easily maintain their daily health habits, a total of 52 products*3 are being sold that are labeled with the functionality of immune functions using L. lactis strain Plasma" in various categories such as beverages, green juice, candy, and jelly, not only Kirin Holdings’ own products but also through collaboration with partner companies. As a result of creating an environment where people can easily get hold of the products and communicating the importance of immune care through TV commercials, in-store POP, and various other lifestyle scenes, The recognition rate of "immune care" has been steadily increasing, with an 8.9-point*4 increase in the recognition rate between January and June 2023. *3 As of July 27, 2023 (Thursday) *4 Kirin research Target: Men and women aged 20-69 nationwide, n=1,035, Survey method: Web, Target data: January 1 (Sunday), Jun 30 (Friday), 2023 Kirin Holdings’ Proprietary Ingredient L. lactis strain Plasma L. lactis strain Plasma is a lactic acid bacteria (postbiotic) that supports the maintenance of immunity in healthy people. It has been reported in research papers that it is the first in the world*5 to work on pDC (plasmacytoid dendritic cells), a leader of the immune system. Kirin Holdings, KOIWAI DAIRY PRODUCTS CO., LTD., and KYOWA HAKKO BIO CO., LTD. have jointly conducted research on this product, and with the cooperation of universities and research institutions in Japan and overseas, 31 papers have been published and numerous presentations made at academic conferences. *5 Lactococcus lactis strain Plasma was the first lactic acid bacteria reported to work on pDC in humans (based on information published in PubMed and the homepage of the Central Medical Journal). Plasma Sales Trends by Category [Beverage] Total sales volume of beverages containing L. lactis strain Plasma increased 35% year-on-year in the period from January to June 2023. The cumulative sales volume*6 of Kirin Oishii Immune Care since its launch has increased 2.1 times that of Kirin iMUSE Morning Immune Care, a significant increase. In June, Kirin Beverage launched two new products, Kirin Oishii Immune Care Calorie Off and Kirin Oishii Immune Care 200ml, a vending machine-only product, expanding the lineup of the Oishii Immune Care series. In particular, Kirin Oishii Immune Care Calorie-Off has been well received for its satisfying taste despite being calorie-free, and is attracting new Oishii Immune Care users. In order to propose “immune care" to consumers throughout the year, Kirin Beverage launched Kirin Plasma Sports in April and launched Kirin Sekai no Kitchen Salty Lychee Plus as a new product that provides "immune care" during sports and daily hydration. *6 Comparison over the same period of 99 days from the date of launch [Yogurt] The sales of Koiwai iMUSE Yogurt series for the cumulative January-June period of 2023 exceeded the previous year's level due to the growing health and immune care awareness associated with environmental changes in recent years, as well as the establishment of consumers who habitually consume and purchase the product. The total sales amount of large-volume type products, in particular, increased by more than double digits from the previous year due to a steady increase in the number of consumers who consume these products as a family or as a habit. [Supplement] Total sales of supplements containing L. lactis strain Plasma increased 35% year on year in the first six months of 2023. Kirin iMUSE Immune Care Visceral Fat Down, which contains “double-care” ingredients, was well received by people who are concerned about fat around the abdomen after their health checkups this spring and people who are concerned about being seen by the public and their immunity due to increased outings. As a result, cumulative sales for the period from January to June were approximately 2.5 times higher than planned. [Partner Company Products] Several new products are also being launched in 2023. KELLOGG (JAPAN) G.K. has released on June 26 All-Bran Immune Care which is the first "meal" type product (as opposed to a side dish or a snack) as a functional food containing L. lactis strain Plasma. Matsukiyo Cocokara & Co has released on Saturday, June 10 matsukiyo LAB Immune care L. lactis strain Plasma with Euglena. With these products, the number of functional food items containing L. lactis strain Plasma sold by ten partner companies has increased to 19 products*7. The development of a broad lineup of functional foods with immune function claims that are tasty and easy to consume has helped to establish an "immune care" habit and boost sales in the L. lactis strain Plasma business. *7 As of July 27, 2023 Future developments [Beverage] The Oishii Immune Care series will continue to meet a wide range of consumer needs by offering a combination of taste and functionality to achieve the instilling of an "immune care" habit. Kirin Plasma Sports and Kirin Sekai no Kitchen Kara Salty Lychee Plus will further strengthen their sales as beverages containing the thirst-quenching L. lactis strain Plasma. [Yogurt] In order to make the product accessible to more people, the design of the top lid of the large-capacity type will be changed from August onward to improve visibility by consumers. [Supplement] In response to the growing number of consumers who are taking Kirin iMUSE Immune Care Supplement on a habitual basis, a new 30-day supply (120 tablets) of Kirin iMUSE Immune Care Supplement will be available at drugstores nationwide from Tuesday, September 26. [Partner Company Products] Noevir Holdings Co., Ltd. have announced the release of Noevir L. lactis strain Plasma Aojiru to go on sale on nationwide stores and general e-commerce channels on September 5. Functional Foods Kirin iMUSE Immune Care Visceral Fat Down ＜Reported Indication＞ This product contains Lactococcus lactis strain Plasma (L. lactis strain Plasma). L. lactis strain Plasma act on pDC (plasma cytoid dendritic cells) and have been reported to help maintain immune function in healthy people. This product contains isoflavones (as tectrigenins) derived from kudzu flowers. Isoflavones (as tectrigenins) derived from kudzu flower have been reported to help reduce body weight, abdominal fat (visceral and subcutaneous fat), and waist circumference in obese people. All-Bran Immune Care ＜Reported Indication＞ This product contains arabinoxylan derived from wheat bran and L. lactis strain Plasma. Wheat bran-derived arabinoxylan is a fermentable dietary fiber that has been reported to improve the intestinal environment by increasing butyric acid bacteria in the intestines, known as good bacteria, and increasing butyric acid. In addition, wheat bran-derived arabinoxylan derived from wheat bran is also reported to improve bowel movements by regulating the condition of the stomach. L. lactis strain Plasma is reported to work on pDC (plasmacytoid dendritic cells) and help maintain immune function in healthy people. Functional foods other than those listed above. ＜Reported Indication＞ This product contains Lactococcus lactis strain Plasma (L. lactis strain Plasma). L. lactis strain Plasma act on pDC (plasma cytoid dendritic cells) and have been reported to help maintain immune function in healthy people. Notes: 1 Diet is based on staple foods, main dishes, and side dishes to balance the diet. 2 These products have not been approved by the government. 3 These products are not intended to diagnose, treat or prevent disease. L. lactis strain Plasma Series Functional Foods: New Product Product name Noevir L. lactis strain Plasma Aojiru Release Date September 5, 2023 Content by volume 30 bags Approx. 1 sachet per day Sold through nationwide stores and general e-commerce channels. Online　Shop【NOEVIR Style】 https://noevirstyle.jp Price (Suggested retail price without consumption tax) 6,500 yen Distributor Noevir Co., Ltd Product Features Green juice made from whole young barley leaves grown without pesticides by contract farmers in Kyushu. Contains euglena, kale, and vitamin D. The lactic acid bacteria drink flavor makes it delicious. Registration No. I3 Product Image Functional Foods ＜Reported Indication＞ This product contains Lactococcus lactis strain Plasma (L. lactis strain Plasma). L. lactis strain Plasma act on pDC (plasma cytoid dendritic cells) and have been reported to help maintain immune function in healthy people. Product name Kirin iMUSE Immune Care Supplement Release Date September 26, 2023 Content by volume 30-day supply: 120 tablets Approx. 4 capsules per day Sold through: Nationwide Drugstores Price (Suggested retail price without consumption tax) 3,500 yen Distributor Kirin Holdings Company, Limited Product Features A supplement to be taken daily with water (dairy-free) containing that L. lactis strain Plasma. Easy-to-swallow small tablet type. Registration No. G777 Product Image Functional Foods ＜Reported Indication＞ This product contains Lactococcus lactis strain Plasma (L. lactis strain Plasma). L. lactis strain Plasma act on pDC (plasma cytoid dendritic cells) and have been reported to help maintain immune function in healthy people. Notes: 1 Diet is based on staple foods, main dishes, and side dishes to balance the diet. 2 These products have not been approved by the government. 3 These products are not intended to diagnose, treat or prevent disease. About Kirin Holdings Kirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe. Kirin Holdings can trace its roots to Japan Brewery which was established in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers. In 2007, Kirin Holdings was established as a pure holding company and is currently focusing on boosting its Health Science domain. Under the Kirin Group Vision 2027 (KV 2027), a long-term management plan launched in 2019, the Kirin Group aims to become A global leader in CSV*, creating value across our world of Food & Beverages to Pharmaceuticals. Going forward, the Kirin Group will continue to leverage its strengths to create both social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value. * Creating Shared Value. Combined added value for consumers as well as for society at large. GALLERY Image Download Plasma Download 「Kirin Oishii Immune Care 100ml PET bottle」 Download 「Koiwai iMUSE Namanyu Yogurt with less sweetness (400g)」 Download 「Koiwai iMUSE Yogurt low fat (400g)」 Download 「Kirin iMUSE Immune Care Visceral Fat Down (15-day)」 Download 「Noevir L. lactis strain Plasma Aojiru」 Download Media Contacts News Releases Integrated Report Share Please do not forward or share information about alcoholic beverages with anyone under the legal drinking age. Purpose Message from Top Management CSV Purpose Long-term Management Vision and Medium-Term Business Plan KIRIN’s HISTORY Corporate Governance Risk Management Value Creation Model Impact CSV management Management Issues for Sustainable Growth (Group Materiality Matrix) A Responsible Alcohol Producer Health and Well-Being Community Engagement The Environment Other material agenda and governance Domains Product brand Food & Beverages Health Science Pharmaceuticals Drivers Core technology that assures value creation Consumer centric marketing ICT accelerating value creation Diversity and inclusion, culture for innovation Financial Strategy Profile Investors Careers Newsroom Contact Us Terms and Conditions Privacy Policy Site Map You must be of legal drinking age to consume alcohol. Don't drink and drive. Enjoy responsibly. It is advisable not to drink alcohol during pregnancy and breastfeeding. Do not litter! Let's recycle after drinking! © 2007-2024 Kirin Holdings Company, Limited. TOP